147 related articles for article (PubMed ID: 1930621)
41. Synthesis of novel naphthoquinone aliphatic amides and esters and their anticancer evaluation.
Kongkathip B; Akkarasamiyo S; Hasitapan K; Sittikul P; Boonyalai N; Kongkathip N
Eur J Med Chem; 2013 Feb; 60():271-84. PubMed ID: 23313636
[TBL] [Abstract][Full Text] [Related]
42. 1-Aryl-1H-pyrazole-5-acetic acids with antiinflammatory, analgesic and other activities.
Menozzi G; Mosti L; Schenone P; D'Amico M; Falciani M; Filippelli W
Farmaco; 1994 Feb; 49(2):115-9. PubMed ID: 8003179
[TBL] [Abstract][Full Text] [Related]
43. Aroylpropionic acid based 2,5-disubstituted-1,3,4-oxadiazoles: synthesis and their anti-inflammatory and analgesic activities.
Akhter M; Husain A; Azad B; Ajmal M
Eur J Med Chem; 2009 Jun; 44(6):2372-8. PubMed ID: 18977556
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, spectral studies and anti-inflammatory activity of glycolamide esters of niflumic acid as potential prodrugs.
Gadad AK; Bhat S; Tegeli VS; Redasani VV
Arzneimittelforschung; 2002; 52(11):817-21. PubMed ID: 12489252
[TBL] [Abstract][Full Text] [Related]
45. 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist.
Poon SF; Eastman BW; Chapman DF; Chung J; Cramer M; Holtz G; Cosford ND; Smith ND
Bioorg Med Chem Lett; 2004 Nov; 14(22):5477-80. PubMed ID: 15482907
[TBL] [Abstract][Full Text] [Related]
46. 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties.
Kumar H; Javed SA; Khan SA; Amir M
Eur J Med Chem; 2008 Dec; 43(12):2688-98. PubMed ID: 18395299
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and anti-inflammatory activity of some novel biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazolidin-3-yl amides.
Deep A; Jain S; Sharma PC
Acta Pol Pharm; 2010; 67(1):63-7. PubMed ID: 20210080
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivatives.
Bahekar SS; Shinde DB
Bioorg Med Chem Lett; 2004 Apr; 14(7):1733-6. PubMed ID: 15026060
[TBL] [Abstract][Full Text] [Related]
50. [Synthesis and properties of 5(4,6-diphenyl-2-pyrimidin-2-yl)-1,2,4-triazolin-3-thione and derivatives ].
Mekuskiene G; Gaidelis P; Vainilavicius P
Pharmazie; 1998 Feb; 53(2):94-8. PubMed ID: 9540106
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and anti-inflammatory activity of some [2-amino-6-(4-substituted aryl)-4-(4-substituted phenyl)-1,6-dihydropyrimidine-5-yl]-acetic acid derivatives.
Bahekar SS; Shinde DB
Acta Pharm; 2003 Sep; 53(3):223-9. PubMed ID: 14769245
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, analgesic and anti-inflammatory evaluation of some new 3H-quinazolin-4-one derivatives.
Alafeefy AM; Kadi AA; El-Azab AS; Abdel-Hamide SG; Daba MH
Arch Pharm (Weinheim); 2008 Jun; 341(6):377-85. PubMed ID: 18535995
[TBL] [Abstract][Full Text] [Related]
53. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of some new 2-(6-methoxy-2-naphthyl)- 5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents.
Narayana B; Vijaya Raj KK; Ashalatha BV; Kumari NS
Arch Pharm (Weinheim); 2005 Aug; 338(8):373-7. PubMed ID: 16041838
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents.
Khode S; Maddi V; Aragade P; Palkar M; Ronad PK; Mamledesai S; Thippeswamy AH; Satyanarayana D
Eur J Med Chem; 2009 Apr; 44(4):1682-8. PubMed ID: 18986738
[TBL] [Abstract][Full Text] [Related]
56. Studies on non-steroidal anti-inflammatory and related biological activities of 5-(indan-1'-yl)tetrazoles and their intermediates.
Ray SM; Roy A; Lahiri SC
Indian J Physiol Pharmacol; 1990 Apr; 34(2):109-14. PubMed ID: 2253978
[TBL] [Abstract][Full Text] [Related]
57. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
58. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity.
Biava M; Porretta GC; Poce G; Supino S; Forli S; Rovini M; Cappelli A; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Vivoli E; Makovec F; Anzellotti P; Patrignani P; Anzini M
J Med Chem; 2007 Nov; 50(22):5403-11. PubMed ID: 17915854
[TBL] [Abstract][Full Text] [Related]
59. Substituted phenylthiophenylamines with antiinflammatory activity.
Bethegnies G; Marcincal-Lefebvre A; Brunet C; Cazin M; Damas J
Farmaco; 1989; 44(7-8):683-94. PubMed ID: 2590366
[TBL] [Abstract][Full Text] [Related]
60. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat.
Sidhapuriwala J; Li L; Sparatore A; Bhatia M; Moore PK
Eur J Pharmacol; 2007 Aug; 569(1-2):149-54. PubMed ID: 17553487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
